PROGNOSTIC SIGNIFICANCE OF ELF TEST COMPARED TO LIVER BIOPSY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0
|
作者：
Liguori, Antonio [1 ]
D'Ambrosio, Francesca [1 ]
Viceconti, Nicholas [1 ]
Termite, Fabrizio [1 ]
Petrucci, Lucrezia [1 ]
Galletti, Simone [1 ]
Cardinali, Sara [1 ]
Riccardi, Laura [1 ]
Pizzolante, Fabrizio [1 ]
De Matthaeis, Nicoletta [1 ]
Zocco, Maria Assunta [1 ]
Giustiniani, Maria Cristina [1 ]
Marrone, Giuseppe [1 ]
Biolato, Marco [1 ]
Rapaccini, Gian Ludovico [1 ]
Pompili, Maurizio [1 ]
Grieco, Antonio [1 ]
Urbani, Andrea [1 ]
Sanguinetti, Maurizio [1 ]
Gasbarrini, Antonio [1 ]
Miele, Luca [1 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Rome, Italy
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
874
引用
收藏
页码：S662 / S662
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, Antonio
    D'Ambrosio, Francesca
    Viceconti, Nicholas
    Termite, Fabrizio
    Petrucci, Lucrezia
    Beschi, Riccardo
    Orienti, Marco
    Cardinali, Sara
    Galletti, Simone
    Riccardi, Laura
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Ainora, Maria Elena
    Zocco, Maria Assunta
    Giustiniani, Maria Cristina
    Marrone, Giuseppe
    Biolato, Marco
    Vecchio, Fabio Maria
    Grieco, Antonio
    Urbani, Andrea
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Miele, Luca
    JOURNAL OF HEPATOLOGY, 2024, 80 : S533 - S533
  • [2] THE PROGNOSTIC ROLE OF THE ELF TEST, COMPARED TO LIVER BIOPSY, IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Liguori, A.
    D'Ambrosio, F.
    Nicholas, V.
    Termite, F.
    Petrucci, L.
    Beschi, R.
    Orienti, M.
    Galletti, S.
    Cardinali, S.
    Riccardi, L.
    Pizzolante, F.
    De, Matthaeis N.
    Zocco, M. A.
    Giustiniani, M. C.
    Marrone, G.
    Biolato, M.
    Cefalo, C.
    Vecchio, F. M.
    Pompili, M.
    Rapaccini, G. L.
    Grieco, A.
    Urbani, A.
    Sanguinetti, M.
    Gasbarrini, A.
    Miele, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S257 - S257
  • [3] Prognostic role of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, A.
    D'Ambrosio, F.
    Viceconti, N.
    Termite, F.
    Petrucci, L.
    Beschi, R.
    Orienti, M.
    Galletti, S.
    Cardinali, S.
    Riccardi, L.
    Garcovich, M.
    Pizzolante, F.
    De Matthaeis, N.
    Zocco, M. A.
    Ainora, M. E.
    Giustiniani, M. C.
    Marrone, G.
    Biolato, M.
    Cefalo, C.
    Vecchio, F. M.
    Grieco, A.
    Urbani, A.
    Sanguinetti, M.
    Gasbarrini, A.
    Miele, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S12 - S12
  • [4] Evolutionary aspects of metabolic dysfunction-associated steatotic liver disease (MASLD)
    Geier, Andreas
    Schiffels, Stephan
    Krawczyk, Marcin
    GASTROENTEROLOGIE, 2025,
  • [5] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Liu, Huan
    Yerevanian, Armen
    Westerhoff, Maria
    Hastings, Margaret H.
    Guerra, Justin Ralph Baldovino
    Zhao, Meng
    Svensson, Katrin J.
    Cai, Bishuang
    Soukas, Alexander A.
    Rosenzweig, Anthony
    DIABETES, 2024, 73 (02) : 260 - 279
  • [6] Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
    Iturbe-Rey, Santiago
    Maccali, Claudia
    Arrese, Marco
    Aspichueta, Patricia
    Oliveira, Claudia P.
    Castro, Rui E.
    Lapitz, Ainhoa
    Izquierdo-Sanchez, Laura
    Bujanda, Luis
    Perugorria, Maria J.
    Banales, Jesus M.
    Rodrigues, Pedro M.
    ATHEROSCLEROSIS, 2025, 400
  • [7] Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine MASLD
    Stefan, Norbert
    Targher, Giovanni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2025, : 226 - 227
  • [8] Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Kasprzak, Paulina
    Kondracka, Adrianna
    Oniszczuk, Tomasz
    Rusinek, Agata
    Oniszczuk, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [9] DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY
    Turan, Dilara
    Ekelik, Merve M.
    Gumussoy, Mesut
    Kiremitci, Saba
    Bodakci, Emin
    Yilmaz, Volkan
    Guvenir, Tugce
    Duman, Serkan
    Ellik, Zeynep Melekolu
    Ozercan, Abdullah Mubin
    Er, Ramazan Erdem
    Karakaya, Fatih
    Sumer, Hale
    Elhan, Atilla H.
    Savas, Berna
    Toruner, Murat
    Idilman, Ramazan
    GASTROENTEROLOGY, 2024, 166 (05) : S1642 - S1642
  • [10] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
12345